Insider trading

Period: 120 months Stock: EOLS Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

20 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

20 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

20 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

20 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
20 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
20 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

20 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
13 Jun 2025
MOATAZEDI DAVID See Remarks
Sold at will
$1.12M 111,323 at 10.05
22.6%
Not planned
18 Mar 2025
MOATAZEDI DAVID See Remarks
Sold on a plan
$1.37M 103,376 at 13.26
16.7%
Planned (10b5-1)
6 Jun 2024
MOATAZEDI DAVID See Remarks
Sold at will
$2.21M 175,940 at 12.59
24.8%
Not planned
5 Jun 2024
MOATAZEDI DAVID See Remarks
Sold at will
$2.01M 155,278 at 12.92
22.5%
Not planned
4 Jun 2024
MOATAZEDI DAVID See Remarks
Sold at will
$1.78M 140,214 at 12.73
20.8%
Not planned
19 Mar 2024
MOATAZEDI DAVID See Remarks
Sold at will
$1.34M 96,566 at 13.92
12.2%
Not planned
16 Oct 2023
Medytox Inc. Former 10% Owner
Sold at will
$12.68M 1,690,663 at 7.50
33.3%
Not planned
15 Aug 2023
Malik Vikram Director
Bought
$1.30M 174,967 at 7.41
174%
First buy on file
17 Feb 2023
Alphaeon 1 LLC 10% owner
Sold, plan not stated
$15.54M 1,850,000 at 8.40
30.5%
7 Feb 2023
Medytox Inc. 10% owner
Sold, plan not stated
$18.59M 2,187,511 at 8.50
30.1%
2 Sep 2021
Alphaeon 1 LLC 10% owner
Sold, plan not stated
$24.68M 2,597,475 at 9.50
30.0%
3 Jun 2019
Sold, plan not stated
$25.00M 1,298,701 at 19.25
13.0%
3 Jun 2019
Malik Vikram Director · indirect
Bought
$25.00M 1,298,701 at 19.25
opened
First buy on file
22 May 2019
Sold, plan not stated
$5.59M 290,518 at 19.25
2.8%
20 May 2019
Sold, plan not stated 2×
$96.59M 5,017,422 at 19.25
32.9%
20 May 2019
BLANK SIMONE Director · indirect
Bought
$12.10M 628,536 at 19.25
213%
First buy on file
29 Nov 2018
Sold, plan not stated
$8.03M 573,888 at 14.00
3.6%
29 Nov 2018
BLANK SIMONE Director · indirect
Bought
$4.13M 295,024 at 14.00
opened
First buy on file
11 Sep 2018
Sold, plan not stated
$36.82M 1,750,000 at 21.04
9.9%
23 Jul 2018
Sold, plan not stated
$18.80M 1,000,000 at 18.80
5.4%
Showing 1–20 of 20.